Literature DB >> 19700330

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.

Jitesh R Shah1, Philip D Mosier, Bryan L Roth, Glen E Kellogg, Richard B Westkaemper.   

Abstract

Histamine H(1) and serotonin 5-HT(2A) receptors present in the CNS have been implicated in various neuropsychiatric disorders. 9-Aminomethyl-9,10-dihydroanthracene (AMDA), a conformationally constrained diarylalkyl amine derivative, has affinity for both of these receptors. A structure-affinity relationship (SAFIR) study was carried out studying the effects of N-methylation, varying the linker chain length and constraint of the aromatic rings on the binding affinities of the compounds with the 5-HT(2A) and H(1) receptors. Homology modeling of the 5-HT(2A) and H(1) receptors suggests that AMDA and its analogs, the parent of which is a 5-HT(2A) antagonist, can bind in a fashion analogous to that of classical H(1) antagonists whose ring systems are oriented toward the fifth and sixth transmembrane helices. The modeled orientation of the ligands are consistent with the reported site-directed mutagenesis data for 5-HT(2A) and H(1) receptors and provide a potential explanation for the selectivity of ligands acting at both receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700330      PMCID: PMC3088504          DOI: 10.1016/j.bmc.2009.08.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  38 in total

1.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.

Authors:  B L Roth; M Shoham; M S Choudhary; N Khan
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

2.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Model structures of alpha-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands.

Authors:  Henri Xhaard; Tommi Nyrönen; Ville-Veikko Rantanen; Jori O Ruuskanen; Jonne Laurila; Tiina Salminen; Mika Scheinin; Mark S Johnson
Journal:  J Struct Biol       Date:  2005-05       Impact factor: 2.867

4.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

5.  Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues.

Authors:  Rasmus P Clausen; Ejner K Moltzen; Jens Perregaard; Sibylle M Lenz; Connie Sanchez; Erik Falch; Bente Frølund; Tina Bolvig; Alan Sarup; Orla M Larsson; Arne Schousboe; Povl Krogsgaard-Larsen
Journal:  Bioorg Med Chem       Date:  2005-02-01       Impact factor: 3.641

Review 6.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 7.  The histamine H4 receptor as a new therapeutic target for inflammation.

Authors:  Iwan J P de Esch; Robin L Thurmond; Aldo Jongejan; Rob Leurs
Journal:  Trends Pharmacol Sci       Date:  2005-09       Impact factor: 14.819

8.  9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.

Authors:  R B Westkaemper; S P Runyon; M L Bondarev; J E Savage; B L Roth; R A Glennon
Journal:  Eur J Pharmacol       Date:  1999-09-03       Impact factor: 4.432

9.  Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.

Authors:  K Wieland; A M Laak; M J Smit; R Kühne; H Timmerman; R Leurs
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 10.  New perspectives for the treatment of disorders of sleep and arousal.

Authors:  D J Sanger; C Soubrane; B Scatton
Journal:  Ann Pharm Fr       Date:  2007-07
View more
  5 in total

1.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

2.  Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.

Authors:  Stevan Pecic; Pooja Makkar; Sandeep Chaudhary; Boojala V Reddy; Hernan A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2010-06-20       Impact factor: 3.641

3.  Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.

Authors:  Beow Keat Yap; Michael J C Buckle; Stephen W Doughty
Journal:  J Mol Model       Date:  2012-02-22       Impact factor: 1.810

4.  9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.

Authors:  Jitesh R Shah; Philip D Mosier; Srinivas Peddi; Bryan L Roth; Richard B Westkaemper
Journal:  Bioorg Med Chem Lett       Date:  2009-12-23       Impact factor: 2.823

5.  Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.

Authors:  Shiu-Wan Chan; Talha Shafi; Robert C Ford
Journal:  Viruses       Date:  2021-11-19       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.